Genetic characterization of metastasis and prognosis in high-grade serous ovarian cancer.

被引：0
|
作者：
Kotnik, Emilee N. [1 ]
Spies, Nicholas C. [1 ]
Li, Tiandao [1 ]
Inkman, Matthew [1 ]
Zhang, Jin [1 ]
Martins-Rodrigues, Fernanda [1 ]
Hagemann, Ian S. [1 ]
McCourt, Carolyn K. [1 ]
Thaker, Premal H. [1 ]
Hagemann, Andrea R. [1 ]
Powell, Matthew A. [1 ]
Mutch, David G. [1 ]
Maher, Christopher A. [1 ]
Miller, Christopher A. [1 ]
Fuh, Katherine C. [1 ]
机构：
[1] Washington Univ, St Louis, MO 63110 USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2202
引用
收藏
页数：2
相关论文
共 50 条
  • [1] AKT Isoforms Interplay in High-Grade Serous Ovarian Cancer Prognosis and Characterization
    Azzalini, Eros
    Tierno, Domenico
    Bartoletti, Michele
    Barbazza, Renzo
    Giorda, Giorgio
    Puglisi, Fabio
    Cecere, Sabrina Chiara
    Losito, Nunzia Simona
    Russo, Daniela
    Stanta, Giorgio
    Canzonieri, Vincenzo
    Bonin, Serena
    CANCERS, 2022, 14 (02)
  • [2] Phenotypic and genomic characterization of intratumoral heterogeneity in high-grade serous ovarian cancer.
    Cunnea, Paula
    Curry, Ed
    Nixon, Katherine
    Wulandari, Ratri
    Thol, Kerstin
    Kwok, Chun Hei
    Ploski, Jennifer
    McNeish, Iain
    Christie, Elizabeth
    Bowtell, David
    Fotopoulou, Christina
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 42 - 42
  • [3] Proteogenomic characterization of high-grade serous ovarian cancer
    McDermott, Jason E.
    Payne, Samuel
    Ray, Debjit
    Petyuk, Vladislav
    Moore, Ronald
    Gritsenko, Marina
    Smith, Richard
    Rodland, Karin
    CANCER RESEARCH, 2016, 76
  • [4] Credentialing ERalpha as target in high-grade serous ovarian cancer.
    Oesterreich, Steffi
    Anderson, Courtney L.
    Sikora, Matthew J.
    Boisen, Michelle M.
    Ma, Tianzhou
    Tseng, George
    Chandran, Uma
    Christie, Alec
    Park, Yongseok
    Luthra, Soumya
    Haluska, Paul
    Mantia-Smaldone, Gina
    Odunsi, Kunle
    McLean, Karen
    Lee, Adrian
    Ellshaev, Esther
    Edwards, Robert P.
    CLINICAL CANCER RESEARCH, 2018, 24 (15) : 122 - 122
  • [5] Modeling the tumor microenvironment of high-grade serous ovarian cancer.
    Balkwill, Frances
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 22 - 22
  • [6] Characterization of candidate factors associated with the metastasis and progression of high-grade serous ovarian cancer
    Liu Huiping
    Zhou Ling
    Cheng Hongyan
    Wang Shang
    Luan Wenqing
    Cai E
    Ye Xue
    Zhu Honglan
    Cui Heng
    Li Yi
    Chang Xiaohong
    中华医学杂志英文版, 2023, 136 (24)
  • [7] Characterization of candidate factors associated with the metastasis and progression of high-grade serous ovarian cancer
    Liu, Huiping
    Zhou, Ling
    Cheng, Hongyan
    Wang, Shang
    Luan, Wenqing
    Cai, E.
    Ye, Xue
    Zhu, Honglan
    Cui, Heng
    Li, Yi
    Chang, Xiaohong
    CHINESE MEDICAL JOURNAL, 2023, 136 (24) : 2974 - 2982
  • [8] Role of tumor location on high-grade serous ovarian cancer prognosis
    Ay, Seval
    Ozyukseler, Deniz Tataroglu
    Basak, Mustafa
    Dulgar, Ozgecan
    Arici, Serdar
    Yildirim, Mahmut Emre
    Gumus, Mahmut
    GINEKOLOGIA POLSKA, 2022, 93 (04) : 284 - 289
  • [9] Molecular analysis of exceptional response in high-grade serous ovarian cancer.
    Garsed, Dale
    Pandey, Ahwan
    Fereday, Sian
    Alsop, Kathryn
    Wouters, Maartje
    Saner, Flurina
    Kennedy, Catherine
    Pearce, Celeste
    Pike, Malcolm
    Ramus, Susan
    Kobel, Martin
    deFazio, Anna
    Goode, Ellen
    Nelson, Brad
    Bowtell, David
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 17 - 18
  • [10] Recurrent gene fusions are common in high-grade serous ovarian cancer.
    Lehtonen, Rainer
    Carpen, Olli
    Huhtinen, Kaisa
    Hynninen, Johanna
    Kaipio, Katja
    Lamminen, Tarja
    Cervera, Alejandra
    Hietanen, Sakari
    Grenman, Seija
    Hautaniemi, Sampsa
    CLINICAL CANCER RESEARCH, 2018, 24 (15) : 108 - 108
12345